Statistics on Biotechnology Use  
Results by fields of operation
Sector Companies. Results in biotechnology for main variables and branches of activity 
Unidades: specified in variables

,Total Companies,Services,Industry and Construction,Agriculture,
No. of companies carrying out R&D in Biotechnology,1.198,760,358,80,
%Companies according to biotechnology used: Genetic code,33,3,42,15,5,30,8,
%Companies according to biotechnology used: Functional units,39,8,43,9,35,3,21,6,
%Companies according to biotechnology used: Cellular and tissue culturing and engineering,24,2,28,2,15,1,26,7,
%Companies according to biotechnology used: Bioprocesses,49,6,39,7,75,1,30,3,
%Companies according to biotechnology used: Sub-cellular organisms,6,7,9,1,2,9,0,
%Companies according to biotechnology used: Bio-computing,23,9,32,4,8,9,9,8,
%Companies according to biotechnology used: Nanobiotechnology,11,2,14,3,6,3,2,8,
%Companies according to biotechnology used: Other,14,6,14,7,10,2,33,8,
Companies in which biotechnology activities are: Main and/or exclusive,644,522,102,19,
Companies in which biotechnology activities are: A secondary line of business,171,93,64,14,
Companies in which biotechnology activities are: A tool necessary for production,383,145,192,46,
%Company by field(s) of ultimate application of biotechnology use: Human Health,47,3,61,9,25,9,4,8,
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture,19,4,21,2,12,8,31,6,
%Company by field(s) of ultimate application of biotechnology use: Food products,32,5,25,9,48,4,24,3,
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production,24,1,22,6,18,8,63,1,
%Company by field(s) of ultimate application of biotechnology use: Environment,14,9,15,3,14,7,12,4,
%Company by field(s) of ultimate application of biotechnology use: Industry,12,8,14,12,3,3,8,
Personnel in R&D in biotechnology (no. of persons),13.615,8.885,3.811,919,
Personnel in R&D in biotechnology (no. of persons): Researchers,7.436,5.473,1.733,231,
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants,6.178,3.412,2.078,688,
Personnel in R&D in biotechnology (no. of persons): women,7.639,5.204,2.016,420,
Personnel in R&D in biotechnology (no. of persons): (women) Researchers,4.095,3.058,918,120,
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants,3.544,2.146,1.098,300,
Personnel in R&D in biotechnology (FTE),9.365,2,6.336,7,2.503,3,525,3,
Personnel in R&D in biotechnology (FTE): Researchers,5.410,6,4.035,2,1.213,7,161,6,
Personnel in R&D in biotechnology (FTE): Technicians and assistants,3.954,6,2.301,4,1.289,6,363,7,
Personnel in R&D in biotechnology (FTE): women,5.385,8,3.708,1,1.422,7,254,9,
Personnel in R&D in biotechnology (FTE): (women) Researchers,3.032,9,2.267,1,681,8,84,
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants,2.352,9,1.441,741,170,9,
Internal expenditure on R&D (thousands of euros),940.230,640.141,263.135,36.954,
1) By nature of the expense: Current expenses,871.813,593.046,244.592,34.175,
1.1) Remuneration to researchers,284.936,194.991,82.018,7.927,
1.2) Remuneration to technicians and assistants,148.254,76.812,61.300,10.143,
1.3) Other current expenses,438.623,321.243,101.274,16.105,
2) By nature of the expense: Capital expenses,68.417,47.095,18.543,2.779,
2.1) Land and buildings,11.763,7.319,2.786,1.659,
2.2) Equipment and instruments,39.641,23.874,14.738,1.028,
2.3) Acquisition of specific R&D software,2.831,2.597,151,83,
2.4) Otros productos de propiedad intelectual específicos para I+D,14.183,13.305,868,10,
1.1) By origin of the funds: Own funds,577.287,340.644,203.482,33.161,
1.2) By origin of the funds: From companies,142.672,134.119,8.553,0,
1.3) By origin of the funds: Public Administration funds,102.630,91.765,9.516,1.350,
1.4) By origin of the funds: From Universities,457,453,5,0,
1.5) By origin of the funds: From non profit private institutions,9.631,9.631,0,0,
1.6) By origin of the funds: Foreign funds,107.553,63.529,41.580,2.444,
Purchase of R&D services in biotechnology (thousands of euros),114.839,57.515,56.730,594,
Purchase of R&D services in biotechnology (thousands of euros): In Spain,69.258,21.868,46.928,462,
Purchase of R&D services in biotechnology (thousands of euros): Abroad,45.581,35.647,9.802,132,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital,41,8,51,5,24,9,25,4,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information,12,10,6,13,6,17,8,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources,13,1,13,5,12,3,12,7,
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain,10,7,12,6,7,6,6,1,
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets,15,1,18,4,8,8,12,1,
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and sales channels,15,7,20,4,6,9,10,2,
%Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception,15,9,17,2,12,9,16,1,
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements,37,40,33,30,
%Companies that consider the following obstacles as very important considering biotechnology development: Time / cost,50,7,55,3,40,9,51,3,
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting,19,18,9,18,24,1,
% Companies that have requested biotechnology patents in Biotechnology,18,3,22,8,11,5,6,
Number of patents requested,643,513,108,22,
% Companies with income of an international origin related to biotechnological activities,24,4,27,22,1,9,5,
% Turnover representing income of an international origin related to biotechnological activities,1,6,5,8,1,3,1,6,
% Income of an international origin related to biotechnological activities distributed in: Income received from the EU,55,7,30,6,63,4,70,6,
% Income of an international origin related to biotechnological activities distributed in: Income received from other countries,44,3,69,4,36,6,29,4,
% Income of an international origin related to biotechnological activities by classification: Internacional trade in products and services,70,3,94,8,62,98,7,
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain,23,9,0,4,31,7,1,3,
% Income of an international origin related with activities according to the classification: Operating source abroad,5,3,2,4,6,3,0,
% Income of an international origin related with activities according to the classification: Other,0,6,2,4,0,0,
Notas:
'.'=numeric piece of data equal to zero not resulting from rounding 

 FTE: Full Time Equivalent
Fuente: National Statistics Institute